P093 TWO DOSE-EQUIVALENT, 21-DAYS, SUBCUTANEOUS (S.C.), GLUCAGON-LIKE PEPTIDE 2 (GLP-2) DOSING REGIMENS, 1.0 MG CONTINUOUSLY VERSUS 0.33 MG THREE TIME DAILY (TID), IN THE TREATMENT OF SHORT BOWEL SYNDROME (SBS) PATIENTS

✍ Scribed by P.B. Jeppesen; I.B. Gottschalck; J.J. Holst; B. Hartman; P.B. Mortensen

• Book ID: 114415859
• Publisher: Elsevier Science
• Year: 2008
• Tongue: English
• Weight: 59 KB
• Volume: 3
• Category: Article
• ISSN: 1744-1161
• DOI: 10.1016/s1744-1161(08)70155-8